C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
2.530
-0.120 (-4.53%)
At close: Nov 17, 2026, 4:00 PM EST
2.520
-0.010 (-0.40%)
After-hours: Nov 17, 2026, 7:41 PM EST
C4 Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 32.43 | 74.6 | 55.5 | 126.59 | 29.75 | 76.12 |
Short-Term Investments | 172.97 | 173.93 | 189.41 | 127.09 | 246.4 | 233.16 |
Cash & Short-Term Investments | 205.4 | 248.54 | 244.9 | 253.68 | 276.15 | 309.28 |
Cash Growth | 7.04% | 1.48% | -3.46% | -8.14% | -10.71% | -16.79% |
Receivables | 1.41 | 2.4 | 3.1 | 11.8 | 1.47 | 5.72 |
Prepaid Expenses | 7.7 | 7.17 | 9.76 | 5.71 | 9.93 | 10.69 |
Total Current Assets | 214.5 | 258.11 | 257.77 | 271.19 | 287.56 | 325.69 |
Property, Plant & Equipment | 40 | 45.28 | 63.38 | 71.09 | 77.52 | 35.05 |
Long-Term Investments | 69.29 | 48.56 | 22.36 | 28.01 | 60.96 | 142.2 |
Other Long-Term Assets | 8.01 | 7.13 | 6.1 | 6.17 | 4.81 | 3.82 |
Total Assets | 331.8 | 359.08 | 349.6 | 376.45 | 430.84 | 506.77 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.96 | 0.86 | 1.33 | 1.45 | 1.17 | 4.51 |
Accrued Expenses | 13.15 | 11.92 | 17.49 | 15.49 | 16.66 | 13.19 |
Current Portion of Long-Term Debt | - | - | - | - | 2.29 | - |
Current Portion of Leases | 6.84 | 6.37 | 5.77 | 5.22 | 4.7 | 1.33 |
Current Unearned Revenue | 19.52 | 12.49 | 18.71 | 15.47 | 16.62 | 31.8 |
Other Current Liabilities | 0.99 | 1.4 | 1.87 | 5.14 | 3.11 | 0.41 |
Total Current Liabilities | 41.46 | 33.03 | 45.18 | 42.77 | 44.55 | 51.25 |
Long-Term Debt | - | - | - | - | 9.2 | 10.77 |
Long-Term Leases | 48.41 | 53.62 | 59.98 | 65.76 | 70.97 | 30.78 |
Long-Term Unearned Revenue | 13.77 | 15.84 | 28.46 | 21.81 | 16.9 | 24.37 |
Total Liabilities | 103.63 | 102.49 | 133.62 | 130.34 | 141.61 | 117.16 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-In Capital | 1,039 | 995.22 | 849.63 | 774.62 | 689.26 | 658.09 |
Retained Earnings | -809.3 | -738.69 | -633.7 | -528.38 | -395.89 | -267.72 |
Comprehensive Income & Other | -1.06 | 0.05 | 0.05 | -0.13 | -4.14 | -0.78 |
Total Common Equity | 228.17 | 256.59 | 215.99 | 246.11 | 289.23 | 389.61 |
Shareholders' Equity | 228.17 | 256.59 | 215.99 | 246.11 | 289.23 | 389.61 |
Total Liabilities & Equity | 331.8 | 359.08 | 349.6 | 376.45 | 430.84 | 506.77 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 55.25 | 59.98 | 65.76 | 70.98 | 87.15 | 42.88 |
Net Cash (Debt) | 219.44 | 237.12 | 201.51 | 210.71 | 249.96 | 408.6 |
Net Cash Growth | 58.67% | 17.67% | -4.37% | -15.70% | -38.82% | 17.16% |
Net Cash Per Share | 1.72 | 2.86 | 2.90 | 4.24 | 5.12 | 8.87 |
Filing Date Shares Outstanding | 131.32 | 97.58 | 70.99 | 68.6 | 49.05 | 48.74 |
Total Common Shares Outstanding | 131.31 | 96.91 | 70.63 | 60.47 | 48.97 | 48.69 |
Working Capital | 173.04 | 225.08 | 212.59 | 228.42 | 243.01 | 274.44 |
Book Value Per Share | 1.74 | 2.65 | 3.06 | 4.07 | 5.91 | 8.00 |
Tangible Book Value | 228.17 | 256.59 | 215.99 | 246.11 | 289.23 | 389.61 |
Tangible Book Value Per Share | 1.74 | 2.65 | 3.06 | 4.07 | 5.91 | 8.00 |
Machinery | 11.04 | 10.97 | 10.37 | 10.18 | 10.66 | 9.48 |
Construction In Progress | - | - | - | - | 0.18 | - |
Leasehold Improvements | 4.55 | 4.55 | 4.71 | 4.71 | 4.68 | 0.54 |